Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study Meeting Abstract
| Authors: | André, T.; Amonkar, M.; Norquist, J.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J.; Smith, D.; Garcia-Carbonero, R.; Sevilla, I.; de la Fouchardiere, C.; Rivera, F.; Elez, E.; Diaz, L. A.; Yoshino, T.; Van Cutsem, E.; Yang, P.; Farooqui, M. Z. H.; Le, D. |
| Abstract Title: | Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S409 |
| Language: | English |
| ACCESSION: | WOS:000573469100396 |
| DOI: | 10.1016/j.annonc.2020.08.507 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 396O -- Source: Wos |
